Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Fluorous Technologies Inc (AKA: FTI)
Profile last edited on: 10/5/12      CAGE: 496T8      UEI:

Business Identifier: Small Molecule Synthesis, Biomolecule Synthesis, and Life Science Applications
Year Founded
2000
First Award
2001
Latest Award
2009
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

970 William Pitt Way
Pittsburgh, PA 15238
   (412) 826-3050
   N/A
   www.fluorous.com
Location: Single
Congr. District: 17
County: Allegheny

Public Profile

Fluorous Technologies Inc. (FTI) is a chemical technology company dedicated to the development and commercialization of fluorous products focused at the life science market. The company uses patented technology to solve synthesis, separation and immobilization problems spanning the entire drug discovery and development process. FTI is developing in partnership with several companies new or improved chemical synthesis and separation processes. The company's technology allows pharmaceutical makers to synthesize a drug more easily and remove impurities

Extent of SBIR involvement

User Avatar
Phase I Awards
8
Phase II Awards
4
Conversion Rate
50.00%
Phase I Dollars
$1,116,564
Phase II Dollars
$3,767,611
Total Awarded
$4,884,175

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2009 2 NIH $1,501,235
Project Title: Fluorous Solution-Phase Synthesis of Peptides and Oligosaccharides
2007 2 NIH $304,377
Project Title: Fluorous Quantitative Proteomics
2005 2 NIH $1,484,141
Project Title: Synthesis and Validation of New Fluorous Scavengers
2004 1 NIH $119,558
Project Title: Chiral separations using fluorous triphasic chemistry
2003 1 NIH $152,441
Project Title: Supported Fluorous Lipids for Triphasic Reactions

Key People / Management

  Philip E Yeske -- President

  Tadamichi Nagashima

  Michael A Parniak

  Nicola L Pohl

  Stephen Weber

  Marvin Yu

Company News

There are no news available.